Non-invasive KRAS and EFGR mutation testing of primary lung cancer via peripheral blood circulating tumour cells This research project focuses on predicting the underlying mutation status of the primary tumour through capture and real-time polymerase chain reaction (PT-PCR) of circulating tumour cells (CTC) DNA.+